Should aminoglycoside antibiotics be abandoned? (Q39223551)

10 September 2017

Should aminoglycoside antibiotics be abandoned? (English)

1 reference

10 September 2017

0 references

English WP

1

1 reference

10 September 2017

Williams MD

series ordinal

2

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

The American Journal of Surgery

10 September 2017

1 reference

10 September 2017

180

1 reference

10 September 2017

6

1 reference

10 September 2017

512-5; discussion 515-6

1 reference

Aminoglycoside nephrotoxicity

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Comparative serum bactericidal activity against Pseudomonas aeruginosa of six antipseudomonal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

What is the cost of nephrotoxicity associated with aminoglycosides?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Risk factors for toxicity in elderly patients given aminoglycosides once daily.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Empiric therapy for pneumonia in the surgical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Surface action of gentamicin on Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Multifactorial analyses in the diagnosis of pneumonia arising in the surgical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Single versus combination antimicrobial therapy for ventilator-associated pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Complications of nosocomial pneumonia in the surgical patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900539-0

10.1016/S0002-9610(00)00539-0

7 January 2021

Identifiers

DOI

1 reference

release_fuq6hqnb7fburdcfrndksoeqeu

10 September 2017

0 references

1 reference